IDEC, Genentech to issue warnings on cancer drug

Article Abstract:

IDEC Pharmaceuticals Corp. and Genentech Inc. will issue letters to physicians regarding the side effects of Rituxan, side effects that were already known. Since there have been eight deaths reported in the one year since the drug was approved, and since a letter was sent to all doctors in Europe, the two drug companies are taking the precaution one step further. The drug, used to treat some lymphomas, caused a breathing problem in the patients who died. The two companies co-market the drug; it is IDEC's only approved drug to date.

Product standards, safety, & recalls, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Anticancer Drugs, Care and treatment, Safety and security measures, Pharmaceutical industry, Abstract, Antineoplastic agents, Genentech Inc., Cancer, Cancer treatment, IDEC Pharmaceuticals Corp., IDPH, GNE

---

Internet IPOs challenge conventional wisdom

Article Abstract:

It seems that online retailers are not the only ones making money these days when they go public. It seems the Internet is becoming profitable from every aspect including for the start-up switch makers who are making fast internet access possible. Companies like Foundry, Extreme and Alteon are finally seeing profits after hanging on to the industry for so long. It would look like this is only the beginning for another craze of Internet related stocks.

Telephone and telegraph apparatus, Telephone Apparatus Manufacturing, Financial analysis, Packet Switching Nodes & Controllers, Computer network equipment industry, Network hardware industry, Forecasts and trends, Industry trend, Securities, Packet switches

---

Similar abstracts:

• Abstracts: Bertelsmann plans Website for book sales via Internet: challenge to Amazon and other pioneers. Once upon a frenzy; book industry in big shift focused on product delivery
• Abstracts: A free personal shopper for Internet news hounds. America Online offers free Internet use in Britain
• Abstracts: Strategic costing and financial reporting. Strategic costing and special studies
• Abstracts: Control of domain names draws alternative proposal; planning the Internet's final privatization. 3-week delay in opening up Internet name registration
• Abstracts: Medtronic to acquire Sofamor Danek in stock deal that could top $3 billion. Acxiom will acquire May & Speh in $625 million stock transaction

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.